Benjamin Bikman

Bikman investigates the intricate mechanisms of metabolic disorders, with a primary focus on insulin resistance, through his work as a professor and researcher. His research aims to uncover how metabolic dysfunction serves as a root cause for chronic diseases like diabetes, obesity, and dementia. By investigating insulin’s pathogenic role, ketone metabolism, and ceramide accumulation, Bikman seeks to provide deeper insights into how these factors disrupt metabolic signaling and energy expenditure.\n\nIn his book "Why We Get Sick," Bikman presents a compelling argument that metabolic health, particularly the management of insulin resistance, is crucial in combating prevalent chronic diseases. The book is crafted to be scientifically rigorous yet accessible, bridging the gap between complex bioenergetic concepts and everyday health practices. This approach not only educates the general public but also empowers them to implement practical strategies for improving metabolic health, thereby reducing the risk of chronic illnesses.\n\nReaders benefit from Bikman's research and writing by gaining a clearer understanding of the metabolic processes that influence health and disease. As a result, his work has significant implications for public health education, particularly in understanding and managing conditions linked to metabolic dysfunction. Bikman's role extends beyond academia into public health, as he actively directs the BYU Diabetes Research Lab and serves as Chief Health Officer for RxSugar, further underlining his commitment to advancing metabolic research and its practical applications.